Urine cystatin C as a biomarker of proximal tubular function immediately after kidney transplantation
- PMID: 21494031
- PMCID: PMC3100377
- DOI: 10.1159/000326753
Urine cystatin C as a biomarker of proximal tubular function immediately after kidney transplantation
Abstract
Background/aims: Clinical methods to predict allograft function soon after kidney transplantation are ineffective.
Methods: We analyzed urine cystatin C (CyC) in a prospective multicenter observational cohort study of deceased-donor kidney transplants to determine its peritransplant excretion pattern, utility for predicting delayed graft function (DGF) and association with 3-month graft function. Serial urine samples were collected for 2 days following transplant and analyzed blindly for CyC. We defined DGF as any hemodialysis in the first week after transplant, slow graft function (SGF) as a serum creatinine reduction < 70% by the first week and immediate graft function (IGF) as a reduction ≥ 70%.
Results: Of 91 recipients, 33 had DGF, 34 had SGF and 24 had IGF. Urine CyC/urine creatinine was highest in DGF for all time-points. The area under the curve (95% CI) for predicting DGF at 6 h was 0.69 (0.57-0.81) for urine CyC, 0.74 (0.62-0.86) for urine CyC/urine creatinine and 0.60 (0.45-0.75) for percent change in urine CyC. On the first postoperative day, urine CyC/urine creatinine and percent change in urine CyC were associated with 3-month graft function.
Conclusion: Urine CyC on the day after transplant differs between degrees of perioperative graft function and modestly corresponds with 3-month function.
Copyright © 2011 S. Karger AG, Basel.
Figures
Similar articles
-
A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation.Transplantation. 2011 Jan 15;91(1):48-56. doi: 10.1097/TP.0b013e3181fc4b3a. Transplantation. 2011. PMID: 21441853
-
Delayed Graft Function Phenotypes and 12-Month Kidney Transplant Outcomes.Transplantation. 2017 Aug;101(8):1913-1923. doi: 10.1097/TP.0000000000001409. Transplantation. 2017. PMID: 27495761 Free PMC article.
-
[Cystatin C as a measure of glomerular filtration in patients with kidney transplants].Srp Arh Celok Lek. 2003 May-Jun;131(5-6):211-4. doi: 10.2298/sarh0306211j. Srp Arh Celok Lek. 2003. PMID: 14692126 Serbian.
-
Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C for Assessing Recovery of Graft Function in Patients Undergoing Living-Donor Kidney Transplantation.Clin Lab. 2016;62(1-2):155-63. doi: 10.7754/clin.lab.2015.150612. Clin Lab. 2016. PMID: 27012045
-
The Perspectives of Biomarkers in Predicting the Survival of the Renal Graft.Front Pediatr. 2022 Jun 3;10:869628. doi: 10.3389/fped.2022.869628. eCollection 2022. Front Pediatr. 2022. PMID: 35722493 Free PMC article. Review.
Cited by
-
A marked elevation in serum creatinine/cystatin C ratio may indicate pseudo-acute kidney injury due to urinary ascites: a case report and literature review.BMC Nephrol. 2023 Aug 21;24(1):243. doi: 10.1186/s12882-023-03289-w. BMC Nephrol. 2023. PMID: 37605159 Free PMC article. Review.
-
Urinary Exosomal Cystatin C and Lipopolysaccharide Binding Protein as Biomarkers for Antibody-Mediated Rejection after Kidney Transplantation.Biomedicines. 2022 Sep 21;10(10):2346. doi: 10.3390/biomedicines10102346. Biomedicines. 2022. PMID: 36289608 Free PMC article.
-
Five-gene signature predicts acute kidney injury in early kidney transplant patients.Aging (Albany NY). 2022 Mar 23;14(6):2628-2644. doi: 10.18632/aging.203962. Epub 2022 Mar 23. Aging (Albany NY). 2022. PMID: 35320116 Free PMC article.
-
The role of specific biomarkers, as predictors of post-operative complications following flexible ureterorenoscopy (FURS), for the treatment of kidney stones: a single-centre observational clinical pilot-study in 37 patients.BMC Urol. 2020 Aug 14;20(1):122. doi: 10.1186/s12894-020-00693-4. BMC Urol. 2020. PMID: 32795278 Free PMC article.
-
Evaluation of Novel Biomarkers for Early Diagnosis of Acute Kidney Injury in Asphyxiated Full-Term Newborns: A Case-Control Study.Med Princ Pract. 2020;29(3):285-291. doi: 10.1159/000503555. Epub 2019 Sep 20. Med Princ Pract. 2020. PMID: 31536999 Free PMC article.
References
-
- Rodrigo E, Ruiz JC, Pinera C, Fernandez-Fresnedo G, Escallada R, Palomar R, Cotorruelo JG, Zubimendi JA, Martin de Francisco AL, Arias M. Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant. 2004;4:1163–1169. - PubMed
-
- Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation. 2008;85:S3–S9. - PubMed
-
- Daly PJ, Power RE, Healy DA, Hickey DP, Fitzpatrick JM, Watson RW. Delayed graft function: a dilemma in renal transplantation. BJU Int. 2005;96:498–501. - PubMed
-
- Johnston O, O'Kelly P, Spencer S, Donohoe J, Walshe JJ, Little DM, Hickey D, Conlon PJ. Reduced graft function (with or without dialysis) vs. immediate graft function – a comparison of long-term renal allograft survival. Nephrol Dial Transplant. 2006;21:2270–2274. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
